Pfizer–BioNTech COVID-19 vaccine
Appearance
mRNA vaccine against COVID-19 from BioNTech in cooperation with Pfizer
નો પેટા-પ્રકાર
COVID-19 vaccine
RNA vaccine
funder
Government of the Federal Republic of Germany[૩]
માલિક
Pfizer
BioNTech
World Health Organisation international non-proprietary name
tozinameran
توزيناميران[૫]
тозинамеран[૬]
托兹奈米瑞[૬]
vaccine for
route of administration
intramuscular injection[૯]
સંદર્ભ
Study to Describe the Safety, Tolerability, Immunogenicity, and Potential Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Adults[૧૬]
Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report[૧૭]
Concurrent human antibody and TH1 type T-cell responses elicited by a COVID-19 RNA vaccine[૧૮]
A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults[૧૯]
Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults[૨૦]
RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study[૨૦]
A Phase I clinical trial of novel coronavirus pneumonia (COVID-19) mRNA Vaccine (BNT162b1) in China[૧૯]
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates[૧૮]
કિંમત/ખર્ચ
NCI Thesaurus ID
C173055
કોમન્સ શ્રેણી
Tozinameran
સંદર્ભ
- ↑ ૧.૦ ૧.૧ European Medicines Agency, ૨૪ ડિસેમ્બર 2020, https://www.ema.europa.eu/en/medicines/human/EPAR/comirnaty, EMEA/H/C/005735
- ↑ ૨.૦ ૨.૧ ૨.૨ ૨.૩ https://covid-19tracker.milkeninstitute.org/, ૧૧ જુલાઇ 2020
- ↑ https://www.reuters.com/article/idUSKBN2661JB
- ↑ ૪.૦ ૪.૧ ૪.૨ ૪.૩ 3, 641–685, https://www.who.int/medicines/publications/druginformation/issues/DrugInformation2020_Vol34-3/en/, WHO Drug Information, અંગ્રેજી, ૨૩ ઓક્ટોબર 2020, List No. 124 – COVID-19 (Special Edition) of Proposed International Nonproprietary Names (INN) for Pharmaceutical Substances, 34
- ↑ ૫.૦ ૫.૧ ૫.૨ ૫.૩ ૫.૪ international nonproprietary name, 11889, https://mednet-communities.net/inn/db/ViewINN.aspx?i=11889, ૨૦ ફેબ્રુઆરી 2021
- ↑ ૬.૦ ૬.૧ 11889
- ↑ https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/anaphylaxis-management.html
- ↑ Suspicions grow that nanoparticles in Pfizer’s COVID-19 vaccine trigger rare allergic reactions
- ↑ https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/pfizer-specific-training_full-deck_19aug.pdf
- ↑ https://www.pfizer.com/products/product-list
- ↑ ૧૨ નવેમ્બર 2020, https://covid-19tracker.milkeninstitute.org/
- ↑ ૧૨ નવેમ્બર 2020, https://www.zeit.de/2020/47/biontech-corona-impfstoff-start-up-pandemie
- ↑ ૧૨ નવેમ્બર 2020, https://www.aerztezeitung.de/Wirtschaft/In-Marburg-statt-Grippe-Vazine-bald-Produktion-von-Corona-Impfstoff-412953.html
- ↑ https://www.reuters.com/article/us-health-coronavirus-vaccines-baxter-in-idUSKBN29I18Y
- ↑ ૪ મે 2021, https://www.who.int/publications/i/item/background-document-on-mrna-vaccine-bnt162b2-(pfizer-biontech)-against-covid-19
- ↑ https://covid-19tracker.milkeninstitute.org/, ૧૨ જુલાઇ 2020
- ↑ https://covid-19tracker.milkeninstitute.org/, ૨૬ ઓગસ્ટ 2020
- ↑ ૧૮.૦ ૧૮.૧ inferred from abstract
- ↑ ૧૯.૦ ૧૯.૧ ૩૦ ઓગસ્ટ 2020, https://covid-19tracker.milkeninstitute.org/
- ↑ ૨૦.૦ ૨૦.૧ inferred from title
- ↑ aljazeera.com, https://www.aljazeera.com/news/2020/12/15/sputnik-v-what-to-know-about-the-russian-vaccine-in-500-words, અંગ્રેજી, ૧૫ ડિસેમ્બર 2020, Sputnik V: What to know about the Russian vaccine, in 500 words
- ↑ Politico Europe, https://www.politico.eu/article/belgian-secretary-of-state-accidentally-reveals-eu-vaccine-prices/, અંગ્રેજી, ૧૭ ડિસેમ્બર 2020, Belgian secretary of state accidentally reveals EU vaccine prices